Select for export An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116684335 PubMed 28095732 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-01-17 Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. Europe PMC Published psilocybin DepressionAddictionMechanism of Action Observational Study More
Select for export Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1573413713666170619092629 PubMed 28625125 Copy citation Copy BibTeX Unknown journal 2016-12-31 Kraehenmann R. Europe PMC Published psilocybin ConsciousnessWellbeingEmotional Processing Review Article More
Select for export Psychedelics as Medicines: An Emerging New Paradigm. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.557 PubMed 28019026 Copy citation Copy BibTeX Unknown journal 2016-12-25 Nichols DE, Johnson MW, Nichols CD. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675754 PubMed 27909163 Copy citation Copy BibTeX Unknown journal 2016-11-30 Nutt D. Europe PMC Published psilocybin DepressionAnxiety Other More
Select for export Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675512 PubMed 27909164 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675513 PubMed 27909165 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Psilocybin: Psychotherapy or drug? No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675757 PubMed 27909167 Copy citation Copy BibTeX Unknown journal 2016-11-30 Goodwin GM. Europe PMC Published psilocybin General Other More
Select for export Psilocybin in end of life care: Implications for further research. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675758 PubMed 27909168 Copy citation Copy BibTeX Unknown journal 2016-11-30 Summergrad P. Europe PMC Published psilocybin End-of-Life Distress Other More
Select for export Psilocybin and palliative end-of-life care. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675764 PubMed 27909170 Copy citation Copy BibTeX Unknown journal 2016-11-30 Shelton RC, Hendricks PS. Europe PMC Published psilocybin End-of-Life Distress Other More
Select for export Psilocybin for depression and anxiety associated with life-threatening illnesses. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675771 PubMed 27909171 Copy citation Copy BibTeX Unknown journal 2016-11-30 McCorvy JD, Olsen RH, Roth BL. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Other More
Select for export The role of psychedelics in palliative care reconsidered: A case for psilocybin. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675781 PubMed 27909173 Copy citation Copy BibTeX Unknown journal 2016-11-30 Kelmendi B, Corlett P, Ranganathan M, D'Souza C, Krystal JH. Europe PMC Published psilocybin End-of-Life Distress Other More
Select for export Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675783 PubMed 27909174 Copy citation Copy BibTeX Unknown journal 2016-11-30 Spiegel D. Europe PMC Published psilocybin Cancer Patients Other More
Select for export Psilocybin: promising results in double-blind trials require confirmation by real-world evidence. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675784 PubMed 27909175 Copy citation Copy BibTeX Unknown journal 2016-11-30 Breckenridge A, Grobbee DE. Europe PMC Published psilocybin General Other More
Select for export Statistical comparison of mass spectra for identification of amphetamine-type stimulants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.forsciint.2016.11.013 PubMed 27936426 Copy citation Copy BibTeX Unknown journal 2016-11-21 Bodnar Willard MA, McGuffin VL, Smith RW. Europe PMC Published psilocybinpsilocin General Other More
Select for export The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116678781 PubMed 27856683 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-16 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAnxietyConsciousness Case Report More
Select for export Psychedelics in the treatment of unipolar mood disorders: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116679368 PubMed 27856684 Copy citation Copy BibTeX Unknown journal 2016-11-16 Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. Europe PMC Published psilocybin DepressionClinical TrialSystematic Review Systematic Review More
Select for export Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neubiorev.2016.10.026 PubMed 27810345 Copy citation Copy BibTeX Unknown journal 2016-10-30 Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC. Europe PMC Published psilocybin Brain ImagingReceptor PharmacologyDefault Mode Network Systematic Review More
Select for export Alterations of consciousness and mystical-type experiences after acute LSD in humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-016-4453-0 PubMed 27714429 Copy citation Copy BibTeX Psychopharmacology 2016-10-06 Liechti ME, Dolder PC, Schmid Y. Europe PMC Published psilocybin Brain ImagingConsciousnessAging Observational Study More
Select for export [New patterns of substance use and abuse among French adolescents, a knowledge synthesis]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.encep.2016.05.012 PubMed 27720453 Copy citation Copy BibTeX Unknown journal 2016-10-05 Jeanne G, Purper-Ouakil D, Rigole H, Franc N. Europe PMC Published psilocybin AddictionPharmacologyReview Article Review Article More
Select for export Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(16)31133-6 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-09-30 Filip Tylš, Čestmír Vejmola, Michaela Viktorinová, L. Kadeřábek, Tomáš Páleníček OpenAlex Published psilocybin Brain ImagingReceptor Pharmacology Other More
